GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neogen Corp (NAS:NEOG) » Definitions » Piotroski F-Score

Neogen (Neogen) Piotroski F-Score

: 6 (As of Today)
View and export this data going back to 1989. Start your Free Trial

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Neogen has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Neogen's Piotroski F-Score or its related term are showing as below:

NEOG' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 7
Current: 6

During the past 13 years, the highest Piotroski F-Score of Neogen was 7. The lowest was 2. And the median was 5.


Neogen Piotroski F-Score Historical Data

The historical data trend for Neogen's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neogen Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Piotroski F-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 5.00 4.00 6.00 4.00

Neogen Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 4.00 4.00 6.00 6.00

Competitive Comparison

For the Diagnostics & Research subindustry, Neogen's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neogen Piotroski F-Score Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Neogen's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Neogen's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Feb24) TTM:Last Year (Feb23) TTM:
Net Income was 5.572 + 1.503 + -3.487 + -2.022 = $1.6 Mil.
Cash Flow from Operations was 90.966 + 23.009 + 15.714 + -30.206 = $99.5 Mil.
Revenue was 241.81 + 228.987 + 229.629 + 228.812 = $929.2 Mil.
Gross Profit was 123.182 + 116.761 + 116.774 + 116.883 = $473.6 Mil.
Average Total Assets from the begining of this year (Feb23)
to the end of this year (Feb24) was
(4508.764 + 4554.432 + 4561.105 + 4602.415 + 4582.492) / 5 = $4561.8416 Mil.
Total Assets at the begining of this year (Feb23) was $4,508.8 Mil.
Long-Term Debt & Capital Lease Obligation was $887.7 Mil.
Total Current Assets was $602.5 Mil.
Total Current Liabilities was $157.8 Mil.
Net Income was 14.959 + 5.209 + -41.841 + 8.19 = $-13.5 Mil.

Revenue was 140.093 + 132.349 + 230.033 + 218.255 = $720.7 Mil.
Gross Profit was 64.999 + 62.27 + 112.539 + 107.964 = $347.8 Mil.
Average Total Assets from the begining of last year (Feb22)
to the end of last year (Feb23) was
(981.205 + 992.929 + 977.405 + 4563.242 + 4508.764) / 5 = $2404.709 Mil.
Total Assets at the begining of last year (Feb22) was $981.2 Mil.
Long-Term Debt & Capital Lease Obligation was $884.7 Mil.
Total Current Assets was $555.4 Mil.
Total Current Liabilities was $107.2 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Neogen's current Net Income (TTM) was 1.6. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Neogen's current Cash Flow from Operations (TTM) was 99.5. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Feb23)
=1.566/4508.764
=0.00034732

ROA (Last Year)=Net Income/Total Assets (Feb22)
=-13.483/981.205
=-0.01374127

Neogen's return on assets of this year was 0.00034732. Neogen's return on assets of last year was -0.01374127. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Neogen's current Net Income (TTM) was 1.6. Neogen's current Cash Flow from Operations (TTM) was 99.5. ==> 99.5 > 1.6 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Feb24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Feb23 to Feb24
=887.653/4561.8416
=0.19458216

Gearing (Last Year: Feb23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Feb22 to Feb23
=884.701/2404.709
=0.36790356

Neogen's gearing of this year was 0.19458216. Neogen's gearing of last year was 0.36790356. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Feb24)=Total Current Assets/Total Current Liabilities
=602.471/157.844
=3.81687616

Current Ratio (Last Year: Feb23)=Total Current Assets/Total Current Liabilities
=555.371/107.155
=5.18287527

Neogen's current ratio of this year was 3.81687616. Neogen's current ratio of last year was 5.18287527. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Neogen's number of shares in issue this year was 216.598. Neogen's number of shares in issue last year was 216.399. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=473.6/929.238
=0.50966491

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=347.772/720.73
=0.48252744

Neogen's gross margin of this year was 0.50966491. Neogen's gross margin of last year was 0.48252744. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Feb23)
=929.238/4508.764
=0.20609595

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Feb22)
=720.73/981.205
=0.7345356

Neogen's asset turnover of this year was 0.20609595. Neogen's asset turnover of last year was 0.7345356. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+0+1+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Neogen has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Neogen  (NAS:NEOG) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Neogen Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Neogen's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Neogen (Neogen) Business Description

Traded in Other Exchanges
Address
620 Lesher Place, Lansing, MI, USA, 48912
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.
Executives
William T Boehm director
Douglas Edward Jones officer: Vice President, CCO 620 LESHER PLACE, LANSING MI 48912
Jason Warren Lilly officer: Vice President 620 LESHER PLACE, LANSING MI 48912
James P Tobin director 620 LESHER PLACE, LANSING MI 48895
David H. Naemura officer: VP & CFO C/O GATES INDUSTRIAL CORPORATION PLC, 1144 FIFTEENTH STREET, SUITE 1400, DENVER CO 80202
Amy M Rocklin officer: Chief Legal & Reg. Officer 620 LESHER PLACE, LANSING MI 48912
Steven J. Quinlan officer: VP & CFO 620 LESHER PLACE, LANSING MI 48912
Jeffrey D Capello director C/O NEOGEN CORP., 620 LESHER PLACE, LANSING MI 48912
Aashima Gupta director C/O NEOGEN CORPORATION, 620 LESHER PLACE, LANSING MI 48912
John Edward Adent officer: Chief Executive Officer 822 7TH STREET, SUITE 740, GREELEY CO 80631
Darci L Vetter director 620 LESHER PLACE, LANSING MI 48912
Ronald D Green director 620 LESHER PLACE, LANSING MI 48912
James C Borel director 1007 MARKET STREET, WILMINGTON DE 19898
Terri A Morrical officer: General Manager
G Bruce Papesh director 726 APPLEGATE LANE, EAST LANSING MI 48823